Oral Nutritional Supplements Containing (n-3) Polyunsaturated Fatty Acids Affect the Nutritional Status of Patients with Stage III Non-Small Cell Lung Cancer during Multimodality Treatment-Reference-Cited by-同舟云学术

Oral Nutritional Supplements Containing (n-3) Polyunsaturated Fatty Acids Affect the Nutritional Status of Patients with Stage III Non-Small Cell Lung Cancer during Multimodality Treatment

Published:2010-08-25 Issue:10 Volume:140 Page:1774-1780
ISSN:0022-3166
Container-title:The Journal of Nutrition
language:en
Short-container-title:

Author:

van der Meij Barbara S.¹,Langius Jacqueline A. E.¹,Smit Egbert F.²,Spreeuwenberg Marieke D.³,von Blomberg B. Mary E.⁴,Heijboer Annemieke C.⁵,Paul Marinus A.⁶,van Leeuwen Paul A. M.⁶

Affiliation:

1. Department of Nutrition and Dietetics, Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands

2. Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands

3. Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands

4. Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands

5. Department of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands

6. Department of Surgery, VU University Medical Center, Amsterdam, The Netherlands

Publisher

Oxford University Press (OUP)

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

http://academic.oup.com/jn/article-pdf/140/10/1774/23947940/1774.pdf

Reference59 articles.

1. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship;Molina;Mayo Clin Proc.,2008

2. Trends in the incidence and death from cancer from 1989–2003 in The Netherlands;Siesling;Ned Tijdschr Geneeskd.,2006

3. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?;Ross;Br J Cancer.,2004

4. Chemoradiation for unresectable stage iii non-small cell lung cancer;Price;Semin Thorac Cardiovasc Surg.,2008

5. Survival after trimodality treatment for superior sulcus and central T4 non-small cell lung cancer;De Leyn;J Thorac Oncol.,2009

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic anticancer effects of omega-3 fatty acids (EPA/DHA) and anticancer drug Doxorubicin against human lung adenocarcinoma;Food Bioscience;2024-10

2. Updates in Cancer Cachexia: Clinical Management and Pharmacologic Interventions;Cancers;2024-04-27

3. Predictive impact of sarcopenia in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A retrospective study;Heliyon;2024-03

4. Impact of serum eicosapentaenoic acid/arachidonic acid ratio on overall survival in lung cancer patients treated with pembrolizumab: a pilot study;Scientific Reports;2024-01-16

5. Omega-3 Fatty Acids Increase Weight and Quality of Life Scores in Patients With Advanced Non-Small Cell Lung Cancer and Cancer Cachexia: A Meta-Analysis;Integrative Cancer Therapies;2024-01